Evidence map›Paper›PMID 39050895›Full record

ArticleFrontiers in cell and developmental biology2024

Mitochondrial inorganic polyphosphate is required to maintain proteostasis within the organelle.

Renata T Da Costa, Pedro Urquiza, Matheus M Perez, YunGuang Du, Mei Li Khong, Haiyan Zheng, Mariona Guitart-Mampel, Pia A Elustondo, Ernest R Scoma, Vedangi Hambardikar and 6 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Renata T Da CostaDepartment of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.
Pedro Urquiza *Department of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.
Matheus M Perez *Department of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.
YunGuang DuDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Amherst, MA, United States.
Mei Li KhongSchool of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Haiyan ZhengCenter for Advanced Biotechnology and Medicine, Rutgers University, New Brunswick, NJ, United States.
Mariona Guitart-MampelDepartment of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.
Pia A ElustondoBiological Mass Spectrometry Core Facility, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
Ernest R ScomaDepartment of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.
Vedangi HambardikarDepartment of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.
Beatrix UeberheideProteomics Laboratory, Division of Advanced Research Technologies, New York University-Grossman School of Medicine, New York City, NY, United States.
Julian A TannerSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Alejandro CohenBiological Mass Spectrometry Core Facility, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
Evgeny V PavlovDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York City, NY, United States.
Cole M HaynesDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Amherst, MA, United States.
Maria E SolesioDepartment of Biology, College of Arts and Sciences, Rutgers University, Camden, NJ, United States.

Funding

Molecular mechanisms of the mitochondrial permeability transitionR35GM139615 · NIGMS · NEW YORK UNIVERSITY · PI PAVLOV, EVGENY · 2021 to 2025
$2.3M
Inorganic polyphosphate as a chaperone in aging and in neurodegenerative diseasesR00AG055701 · NIA · RUTGERS THE STATE UNIV OF NJ CAMDEN · PI SOLESIO TORREGROSA, MARIA DE LA ENCARNACION · 2019 to 2021
$733k
Inorganic polyphosphate as a chaperone in aging and in neurodegenerative diseasesK99AG055701 · NIA · NEW YORK UNIVERSITY · PI SOLESIO TORREGROSA, MARIA DE LA ENCARNACION · 2018 to 2019
$258k
NIA NIH HHS K99 AG055701NIA NIH HHS R00 AG055701NIGMS NIH HHS R35 GM139615
6 · The paper itself

Abstract

The existing literature points towards the presence of robust mitochondrial mechanisms aimed at mitigating protein dyshomeostasis within the organelle. However, the precise molecular composition of these mechanisms remains unclear. Our data show that inorganic polyphosphate (polyP), a polymer well-conserved throughout evolution, is a component of these mechanisms. In mammals, mitochondria exhibit a significant abundance of polyP, and both our research and that of others have already highlighted its potent regulatory effect on bioenergetics. Given the intimate connection between energy metabolism and protein homeostasis, the involvement of polyP in proteostasis has also been demonstrated in several organisms. For example, polyP is a bacterial primordial chaperone, and its role in amyloidogenesis has already been established. Here, using mammalian models, our study reveals that the depletion of mitochondrial polyP leads to increased protein aggregation within the organelle, following stress exposure. Furthermore, mitochondrial polyP is able to bind to proteins, and these proteins differ under control and stress conditions. The depletion of mitochondrial polyP significantly affects the proteome under both control and stress conditions, while also exerting regulatory control over gene expression. Our findings suggest that mitochondrial polyP is a previously unrecognized, and potent component of mitochondrial proteostasis.

Indexed as

mitochondriamitochondrial inorganic polyphosphatepolyPprotein homeostasisproteostasis

Identifiers

PMID39050895
PMCPMC11266304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.